Wednesday, December 09, 2020 10:07:41 AM
“We expect to be able to start processing COVID-19 tests in our new lab by mid-January and are seeking to build capacity to process up to 50,000 COVID-19 tests per day by the end of Q1 2021," stated Ted Karkus, CEO.
ProPhase Labs is also ahead of schedule with the development of its first CLIA lab in New Jersey. The company plans to achieve its original goal beore year-end to have capacity to process 8,000 to 10,000 tests per day in Q1 2021.
https://seekingalpha.com/news/3642755-prophase-labs-expands-covidminus-19-testing-capacity-in-new-york-sharesplus-21?
Were we at PRED?????????????????????
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM